<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="ro">
	<id>https://wiki.tradeville.ro/index.php?action=history&amp;feed=atom&amp;title=Black_Diamond_Therapeutics%2C_Inc</id>
	<title>Black Diamond Therapeutics, Inc - Revizia istoricului</title>
	<link rel="self" type="application/atom+xml" href="https://wiki.tradeville.ro/index.php?action=history&amp;feed=atom&amp;title=Black_Diamond_Therapeutics%2C_Inc"/>
	<link rel="alternate" type="text/html" href="https://wiki.tradeville.ro/index.php?title=Black_Diamond_Therapeutics,_Inc&amp;action=history"/>
	<updated>2026-05-10T21:33:00Z</updated>
	<subtitle>Istoricul versiunilor pentru această pagină din wiki</subtitle>
	<generator>MediaWiki 1.39.2</generator>
	<entry>
		<id>https://wiki.tradeville.ro/index.php?title=Black_Diamond_Therapeutics,_Inc&amp;diff=409013&amp;oldid=prev</id>
		<title>Admin: Pagină nouă: Pagina dedicata companiei Black Diamond Therapeutics, Inc listata cu simbolul US.BDTX  ==Descriere companie== Black Diamond Therapeutics, Inc. (www.blackdiamondtherapeutics.com) is a precision oncology medicine company. The Company is focused on the discovery and development of small molecule, MasterKey therapies. The Company’s technology platform, Mutation-Allostery-Pharmacology (MAP) platform, is designed to allow it to analyze population-level genetic sequencing data to...</title>
		<link rel="alternate" type="text/html" href="https://wiki.tradeville.ro/index.php?title=Black_Diamond_Therapeutics,_Inc&amp;diff=409013&amp;oldid=prev"/>
		<updated>2024-09-18T13:41:44Z</updated>

		<summary type="html">&lt;p&gt;Pagină nouă: Pagina dedicata companiei Black Diamond Therapeutics, Inc listata cu simbolul US.BDTX  ==Descriere companie== Black Diamond Therapeutics, Inc. (www.blackdiamondtherapeutics.com) is a precision oncology medicine company. The Company is focused on the discovery and development of small molecule, MasterKey therapies. The Company’s technology platform, Mutation-Allostery-Pharmacology (MAP) platform, is designed to allow it to analyze population-level genetic sequencing data to...&lt;/p&gt;
&lt;p&gt;&lt;b&gt;Pagină nouă&lt;/b&gt;&lt;/p&gt;&lt;div&gt;Pagina dedicata companiei Black Diamond Therapeutics, Inc listata cu simbolul US.BDTX&lt;br /&gt;
&lt;br /&gt;
==Descriere companie==&lt;br /&gt;
Black Diamond Therapeutics, Inc. (www.blackdiamondtherapeutics.com) is a precision oncology medicine company. The Company is focused on the discovery and development of small molecule, MasterKey therapies. The Company’s technology platform, Mutation-Allostery-Pharmacology (MAP) platform, is designed to allow it to analyze population-level genetic sequencing data to discover oncogenic mutations that promote cancer across tumor types. Its lead product candidate, BDTX-189, is designed as an orally available, irreversible small molecule inhibitor that targets a spectrum of 48 non-canonical and canonical driver mutations of the ErbB kinases epidermal growth factor receptor (EGFR) and HER2. BDTX-1535 is designed as a brain-penetrant small molecule inhibitor that targets a spectrum of EGFR mutations, including allosteric and canonical mutations. It also has early-stage programs, such as B-Raf Proto-Oncogene (BRAF), and fibroblast growth factor receptor (FGFR).&lt;br /&gt;
&lt;br /&gt;
==Grafic actiuni companie==&lt;br /&gt;
&amp;lt;iframe key=&amp;quot;tradeville&amp;quot; path=&amp;quot;graficSimbol/US.BDTX&amp;quot; /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Ultimele stiri despre Black Diamond Therapeutics, Inc (US.BDTX)==&lt;br /&gt;
&amp;lt;dynamicpagelist&amp;gt;&lt;br /&gt;
category=US.BDTX&lt;br /&gt;
count=10&lt;br /&gt;
order=descending&lt;br /&gt;
addfirstcategorydate=false&lt;br /&gt;
&amp;lt;/dynamicpagelist&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Categorie:US.BDTX]][[Categorie:Stiri despre companii]]&lt;/div&gt;</summary>
		<author><name>Admin</name></author>
	</entry>
</feed>